P2-402: Double-blind, placebo-controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1995 ◽
Vol 155
(16)
◽
pp. 1766-1772
◽
Keyword(s):
2001 ◽
Vol 49
(12)
◽
pp. 1590-1599
◽
2008 ◽
Vol 32
(6)
◽
pp. 1538-1544
◽